Amplifon (OTCMKTS:AMFPF) Shares Gap Up - Still a Buy?

Key Points

• Amplifon shares gapped up premarket to $10.0875 from $9.46, but the move occurred on light volume (about 1,600 shares), suggesting limited trading interest behind the jump.
• Jefferies downgraded the stock from a Strong Buy to a Hold, while the consensus remains a Moderate Buy (two Buys, one Hold).
• The stock trades well below its 50‑day ($14.97) and 200‑day ($16.18) moving averages and has a $2.27B market cap, P/E of 18.01, low current ratio (0.62) and debt/equity of 1.14, pointing to weaker liquidity and notable leverage.

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report)'s share price gapped up prior to trading on Tuesday . The stock had previously closed at $9.46, but opened at $10.0875. Amplifon shares last traded at $10.0875, with a volume of 1,600 shares changing hands.

Analyst Ratings Changes

Separately, Jefferies Financial Group downgraded shares of Amplifon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 18th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Amplifon presently has a consensus rating of "Moderate Buy".

Amplifon Price Performance

The firm has a 50-day simple moving average of $14.97 and a 200-day simple moving average of $16.18. The firm has a market cap of $2.27 billion, a P/E ratio of 18.01 and a beta of 0.46. The company has a current ratio of 0.62, a quick ratio of 0.54 and a debt-to-equity ratio of 1.14.

Amplifon Company Profile

Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.

Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.